LIGAND PHARMACEUTICALS INC - COM NEW (LGND)

Q4 2020 13F Holders as of 12/31/2020

Type / Class
Equity / COM NEW
Number of holders
232
Total Shares
22.8M
Shares change
-92K
Total reported value, excl. options
$2.26B
Value change
-$7.35M
Put/Call ratio
2.75
Number of buys
98
Number of sells
-132
Price
$99.45
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.